Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: prespecified substudy from REDUCE-AM

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Mr Philip Leissner

Uppsala University, Uppsala (Sweden)

7 More presentations in this session

Presentation thumbnail

Effects of Beta-Blockers on Quality of Life and Well-being in Patients with Myocardial Infarction and Preserved Left Ventricular Function - a prespecified substudy from REDUCE-AMI

Associate Professor R. Hofmann (Stockholm, SE)

Presentation thumbnail

Coronary computed tomography angiography guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART trial

Professor M. Williams (Edinburgh, GB)

Presentation thumbnail

Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease

Doctor C. Bork (Aalborg, DK)

Presentation thumbnail

Cardiorenal effects and safety of initiation of empagliflozin after acute myocardial infarction

Professor D. Bhatt (New York City, US)

Presentation thumbnail

Cardiovascular Risk Scoring or CT Angiography for Lifestyle and Risk Factor Modification in Primary Prevention of Cardiovascular Disease The SCOT-HEART 2 IMPACT Study

Doctor M. Mcdermott (Edinburgh, GB)

Access the full session

Session thumbnail

Smaller trials, trial updates, and other studies on coronary artery disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Webinar

Are beta-blockers still indicated after myocardial infarction?

Congress Presentation

Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction

Congress Presentation

Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources